Tol1, a Fission Yeast Phosphomonoesterase, Is an In Vivo Target of Lithium, and Its Deletion Leads to Sulfite Auxotrophy
Lithium is the drug of choice for the treatment of bipolar affective disorder. The identification of an in vivo target of lithium in fission yeast as a model organism may help in the understanding of lithium therapy. For this purpose, we have isolated genes whose overexpression improved cell growth...
Gardado en:
| Publicado en: | J Bacteriol |
|---|---|
| Principais autores: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
2000
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC94529/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10850973/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jb.182.13.3619-3625.2000 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
